These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38965928)

  • 1. An overview of lipid constituents in lipid nanoparticle mRNA delivery systems.
    Wu S; Lin L; Shi L; Liu S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1978. PubMed ID: 38965928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M; Li Y; Bloomer H; Xu Q
    Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines.
    Li Z; Zhang XQ; Ho W; Li F; Gao M; Bai X; Xu X
    ACS Nano; 2022 Nov; 16(11):18936-18950. PubMed ID: 36269150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating Lipid Nanoparticles with Histidinamide-Conjugated Cholesterol for Improved Intracellular Delivery of mRNA.
    Jung O; Jung HY; Thuy LT; Choi M; Kim S; Jeon HG; Yang J; Kim SM; Kim TD; Lee E; Kim Y; Choi JS
    Adv Healthc Mater; 2024 Jun; 13(14):e2303857. PubMed ID: 38344923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design and combinatorial chemistry of ionizable lipids for RNA delivery.
    Xu Y; Golubovic A; Xu S; Pan A; Li B
    J Mater Chem B; 2023 Jul; 11(28):6527-6539. PubMed ID: 37345430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines.
    Swetha K; Kotla NG; Tunki L; Jayaraj A; Bhargava SK; Hu H; Bonam SR; Kurapati R
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids and Lipid Derivatives for RNA Delivery.
    Zhang Y; Sun C; Wang C; Jankovic KE; Dong Y
    Chem Rev; 2021 Oct; 121(20):12181-12277. PubMed ID: 34279087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.
    Pilkington EH; Suys EJA; Trevaskis NL; Wheatley AK; Zukancic D; Algarni A; Al-Wassiti H; Davis TP; Pouton CW; Kent SJ; Truong NP
    Acta Biomater; 2021 Sep; 131():16-40. PubMed ID: 34153512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.
    Park S; Choi YK; Kim S; Lee J; Im W
    J Chem Inf Model; 2021 Oct; 61(10):5192-5202. PubMed ID: 34546048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.
    Schoenmaker L; Witzigmann D; Kulkarni JA; Verbeke R; Kersten G; Jiskoot W; Crommelin DJA
    Int J Pharm; 2021 May; 601():120586. PubMed ID: 33839230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of, and expectations for, lipid nanoparticle technology: From cellular targeting to organelle targeting.
    Sato Y; Nakamura T; Yamada Y; Harashima H
    J Control Release; 2024 Jun; 370():516-527. PubMed ID: 38718875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery.
    Tilstra G; Couture-Senécal J; Lau YMA; Manning AM; Wong DSM; Janaeska WW; Wuraola TA; Pang J; Khan OF
    J Am Chem Soc; 2023 Feb; 145(4):2294-2304. PubMed ID: 36652629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Lab.
    Jarzebska NT; Frei J; Mellett M; Kündig TM; Pascolo S; Reichmuth AM
    Methods Mol Biol; 2024; 2786():237-254. PubMed ID: 38814398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery.
    Patel SK; Billingsley MM; Mukalel AJ; Thatte AS; Hamilton AG; Gong N; El-Mayta R; Safford HC; Merolle M; Mitchell MJ
    Theranostics; 2024; 14(1):1-16. PubMed ID: 38164140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Lipid Nanoparticles for the Delivery of Macromolecules Based on the Molecular Design of pH-Sensitive Cationic Lipids.
    Sato Y
    Chem Pharm Bull (Tokyo); 2021; 69(12):1141-1159. PubMed ID: 34853281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
    Tenchov R; Bird R; Curtze AE; Zhou Q
    ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
    Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
    J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscale platforms for messenger RNA delivery.
    Li B; Zhang X; Dong Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1530. PubMed ID: 29726120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.